Ken Griffin Evogene Ltd. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Evogene Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 23,000 shares of EVGN stock, worth $14,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,000

Previous 2,100 995.24%

Holding current value

$14,490

Previous $1,000 1600.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.7 - $0.98 $2,233 - $3,127	3,191 Added 5.63%	59,911 $44,000
Q4 2023 Feb 14, 2024	BUY	$0.47 - $0.88 $13,739 - $25,724	29,232 Added 106.34%	56,720 $47,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.41 $8,926 - $21,701	15,391 Added 127.23%	27,488 $16,000
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.2 $25,104 - $53,796	-44,830 Reduced 78.75%	12,097 $12,000
Q1 2023 May 15, 2023	SELL	$0.59 - $0.86 $16,284 - $23,736	-27,601 Reduced 32.65%	56,927 $35,000

Q4 2022 Feb 14, 2023	SELL	$0.61 - $0.78 $7,426 - $9,496	-12,175 Reduced 12.59%	84,528 $59,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $1.27 $70,593 - $122,812	96,703 New	96,703 $80,000
Q1 2022 May 16, 2022	SELL	$1.09 - $1.83 $93,141 - $156,375	-85,451 Reduced 84.86%	15,244 $20,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $2.83 $41,291 - $71,689	25,332 Added 33.61%	100,695 $165,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $93,692 - $131,934	-38,242 Reduced 33.66%	75,363 $199,000
Q2 2021 Aug 16, 2021	SELL	$3.3 - $5.02 $129,198 - $196,538	-39,151 Reduced 25.63%	113,605 $388,000
Q1 2021 May 17, 2021	BUY	$4.29 - $9.94 $655,323 - $1.52 Million	152,756 New	152,756 $770,000
Q4 2019 Feb 14, 2020	SELL	$1.29 - $1.69 $24,993 - $32,743	-19,375 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.37 - $1.7 $7,570 - $9,394	5,526 Added 39.9%	19,375 $30,000
Q4 2018 Feb 14, 2019	BUY	$1.98 - $3.01 $27,421 - $41,685	13,849 New	13,849 $27,000

Others Institutions Holding EVGN

# of Institutions

Shares Held

4.08M

Call Options Held

23K

Put Options Held

View Full List

About Evogene Ltd.

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $26M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

More about EVGN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account